Piper Jaffray

In a report published Wednesday, Piper Jaffray analyst Peter P. Appert reiterated an Overweight rating on FactSet Research Systems (NYSE: FDS), but lowered the price target from $121.00 to $119.00. In the report, Piper Jaffray noted, “The market was unimpressed with FactSet's in-line F3Q...

In a report published Wednesday, Piper Jaffray analyst Stephanie S. Wissink reiterated a Neutral rating on Body Central (NASDAQ: BODY), and raised the price target from $9.00 to $11.00. In the report, Piper Jaffray noted, “Following our hosted discussion with BODY management at our conference...

In a report published Wednesday, Piper Jaffray analyst Gene Munster reiterated an Overweight rating on MercadoLibre (NASDAQ: MELI), and raised the price target from $123.00 to $151.00. In the report, Piper Jaffray noted, “The key long term question for shares of MELI is what should the leader...

In a report published Tuesday, Piper Jaffray analyst Charles C. Duncan reiterated an Overweight rating on Clovis Oncology (NASDAQ: CLVS), but lowered the price target from $100.00 to $87.00. In the report, Piper Jaffray noted, “We are adjusting our price target for Clovis Oncology to reflect...

In a report published Tuesday, Piper Jaffray analyst Stephanie S. Wissink reiterated a Neutral rating on The Wet Seal (NASDAQ: WTSL), and raised the price target from $4.50 to $5.50. In the report, Piper Jaffray noted, “Following a hosted meeting with WTSL management at our Consumer Conference...

In a report published on Monday, Piper Jaffray analyst Matt Miksic reiterated an Overweight rating on Globus Medical (NYSE: GMED) and maintained a $22 price target on the company. In the report, Piper Jaffray commented that, "The jury award related to the Synthes patent case was roughly in line...

In a report published Monday, Piper Jaffray analyst M. Ian Somaiya reiterated an Overweight rating and $27.00 price target on Incyte (NASDAQ: INCY). In the report, Piper Jaffray noted, “We reiterate our Overweight rating and $27 price target following the presentation of 3-year survival data...

In a report published Monday, Piper Jaffray analyst Peter J. Keith reiterated an Overweight rating on Lumber Liquidators (NYSE: LL), and raised the price target from $90.00 to $97.00. In the report, Piper Jaffray noted, “We are reiterating our Overweight rating and raising our price target to $...

In a report published on Monday, Piper Jaffray analyst Peter J. Keith raised the price target on Tile Shop (NASDAQ: TTS) from $29 to $33 and maintained a rating of Overweight on the company. In the report, Piper Jaffray stated, "While no new information was discussed in regards to Q2, our own...

In a report published on Monday, Piper Jaffray analyst Andrew Nowinski reiterated a Neutral rating on Fusion-io (NYSE: FIO) and lowered the price target from $18.00 to $15.00. In the report, Piper Jaffray stated, “Sentiment surrounding shares of FIO still remains starkly negative, evidenced...